Works matching Moderna Inc.
Results: 228
Stevens–Johnson syndrome precipitated by Moderna Inc. COVID‐19 vaccine: a case‐based review of literature comparing vaccine and drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 8, p. 923, doi. 10.1111/ijd.16222
- By:
- Publication type:
- Article
Desarrollo de un modelo de gestión de la inteligencia organizacional para la compañía Gráficas Modernas S.A.
- Published in:
- Universidad & Empresa, 2015, v. 17, n. 29, p. 63
- By:
- Publication type:
- Article
Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID‑19 antibody production by vaccination in chemotherapy with CD20 antibody for B‑cell lymphoma.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 19, n. 6, p. N.PAG, doi. 10.3892/mco.2023.2692
- By:
- Publication type:
- Article
Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 10, p. 837, doi. 10.1002/phar.2622
- By:
- Publication type:
- Article
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 1889, doi. 10.1007/s13555-021-00610-z
- By:
- Publication type:
- Article
Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
2904. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S84, doi. 10.1093/ofid/ofz359.182
- By:
- Publication type:
- Article
COVID-19: Characteristics and Therapeutics.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 206, doi. 10.3390/cells10020206
- By:
- Publication type:
- Article
Moderna announces it has shipped variant-specific vaccine candidate, mRNA-1273.351, to NIH for clinical study: Company also provides update on strategy for addressing SARS-CoV-2 variants of concern.
- Published in:
- Rhode Island Medical Journal, 2021, v. 104, n. 2, p. 90
- Publication type:
- Article
Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine.
- Published in:
- Neonatology Today, 2020, v. 15, n. 12, p. 96
- By:
- Publication type:
- Article
COVID-19 vaccination campaigns take shape.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 4, p. 282, doi. 10.1093/ajhp/zxab019
- By:
- Publication type:
- Article
Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Towards a Prophylactic Vaccine for the Prevention of HCMV Infection.
- Published in:
- Vaccines, 2021, v. 9, n. 9, p. 968, doi. 10.3390/vaccines9090968
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding "Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults".
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 11, p. 2457, doi. 10.1007/s40121-024-01039-5
- By:
- Publication type:
- Article
A Response to: A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework'.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 10, p. 2195, doi. 10.1007/s40121-024-01020-2
- By:
- Publication type:
- Article
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 69, n. 51/52, p. 1653, doi. 10.15585/mmwr.mm695152e1
- By:
- Publication type:
- Article
mRNA-1273 COVID-19 vaccine-induced Steven–Johnson syndrome.
- Published in:
- QJM: An International Journal of Medicine, 2023, v. 116, n. 3, p. 247, doi. 10.1093/qjmed/hcac282
- By:
- Publication type:
- Article
665-P: Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg vs. 1.0 mg by Baseline HbA1c and BMI: SUSTAIN FORTE Subgroup Analyses.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-665-P
- By:
- Publication type:
- Article
65-LB: Real-World Continuous Glucose Monitoring Data on Time-in-Range from a U.S. Population, 2015–2019.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-65-LB
- By:
- Publication type:
- Article
101-OR: Efficacy and Safety of Once-Weekly Semaglutide 2.0 vs. 1.0 mg for Type 2 Diabetes: SUSTAIN FORTE Randomized Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-101-OR
- By:
- Publication type:
- Article
Phase 3 Trial of Combination Flu/SARS-CoV-2 Vaccine Meets All Primary Endpoints: Moderna.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
FDA Approves Moderna's mRESVIA, First mRNA Vaccine Against RSV, for Adults Aged ≥60 Years.
- Published in:
- Patient Care (Online), 2024, p. 3
- Publication type:
- Article
Moderna, Pfizer Vaccines Work Better in Men: New Research.
- Published in:
- Indian Practitioner, 2021, v. 74, n. 5, p. 46
- Publication type:
- Article
Baby Born to Partially Vaccinated Mother Has Covid Antibodies.
- Published in:
- Indian Practitioner, 2021, v. 74, n. 3, p. 51
- Publication type:
- Article
Business: The billion-dollar biotech.
- Published in:
- Nature, 2015, v. 522, n. 7554, p. 26, doi. 10.1038/522026a
- By:
- Publication type:
- Article
Stéphane Bancel.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 6, p. 378, doi. 10.1038/nrd4646
- Publication type:
- Article
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 325, n. 9, p. 898, doi. 10.1001/jama.2021.1375
- By:
- Publication type:
- Article
market solutions.
- Published in:
- 2007
- Publication type:
- Product Review
Self-Reported Reactogenicity After Different COVID-19 Vaccination Regimens: An Analysis of Registry-Based Data.
- Published in:
- Deutsches Ärzteblatt International, 2022, v. 119, n. 43, p. 727, doi. 10.3238/arztebl.m2022.0298
- By:
- Publication type:
- Article
COVID-19 Vaccine-induced Skin Rash: A Case Study.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
INNOVATIVE RESILIENCE: ASSESSING VACCINE PORTFOLIO PERFORMANCE DURING THE PANDEMIC THROUGH ALTERNATIVE DATA SOURCES.
- Published in:
- Applied Research in Studies & Practice / Taikomieji Tyrimai Studijose ir Praktikoje, 2024, v. 20, n. 1, p. 259
- By:
- Publication type:
- Article
Tramadol versus codéine.
- Published in:
- Médecine, 2022, v. 18, n. 1, p. 13, doi. 10.1684/med.2022.729
- By:
- Publication type:
- Article
In Pflzer We Trust?
- Published in:
- Social Policy, 2020, v. 50, n. 4, p. 86
- By:
- Publication type:
- Article
THE GORDON WILSON LECTURE: RAPID COVID-19 VACCINE DEVELOPMENT AND THE FUTURE OF VACCINOLOGY.
- Published in:
- Transactions of the American Clinical & Climatological Association, 2023, v. 133, p. 103
- By:
- Publication type:
- Article
Big Pharma and Omicron.
- Published in:
- CounterPunch, 2021, p. 1
- By:
- Publication type:
- Article
Why Moderna Refuses to Share Rights to the COVID-19 Vaccine With the Government That Paid for Its Development.
- Published in:
- CounterPunch, 2021, p. 1
- By:
- Publication type:
- Article
Why Are Moderna's Billionaires Airbrushing Scientists Out of the Vaccine Patent Picture?
- Published in:
- CounterPunch, 2021, p. 1
- By:
- Publication type:
- Article
An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccination.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Moderna's $450-million venture round.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 2, p. 119, doi. 10.1038/nbt0215-119d
- Publication type:
- Article
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 3, p. 1550, doi. 10.1007/s12325-025-03112-y
- By:
- Publication type:
- Article
The Mechanism of Nonenzymatic Template Copying with Imidazole‐Activated Nucleotides.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 32, p. 10926, doi. 10.1002/ange.201902050
- By:
- Publication type:
- Article
Role of Cholesterol and its Biosynthetic Precursors on Membrane Organization and Dynamics: A Fluorescence Approach.
- Published in:
- Journal of Membrane Biology, 2023, v. 256, n. 2, p. 189, doi. 10.1007/s00232-023-00278-w
- By:
- Publication type:
- Article
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00656-4
- By:
- Publication type:
- Article
The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00524-7
- By:
- Publication type:
- Article
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00487-9
- By:
- Publication type:
- Article